This inventor holds 3 USPTO granted patents. Top assignee: Smithkline Beecham Corporation. Active years: 2008-2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008-2009
Title: Joseph Marino: Innovator in Pharmaceutical Compounds
Introduction
Joseph Marino is a prominent inventor based in King of Prussia, Pennsylvania. With a remarkable portfolio of three patents, he has made significant contributions to the field of pharmaceuticals. His work focuses on the development of compounds that have substantial therapeutic potential.
Latest Patents
One of Joseph Marino's latest patents is titled "Acid and Ester Compounds and Methods of Using the Same." This patent discloses a unique compound characterized by its formula, which includes pharmaceutically acceptable salts or solvates. It emphasizes the usefulness of these compounds as LXR agonists, indicating their potential role in drug development. Additionally, another patent related to compounds and methods further showcases his innovative approach to pharmaceutical research.
Career Highlights
Throughout his career, Joseph Marino has been associated with the SmithKline Beecham Corporation, a leading firm in the pharmaceutical industry. His expertise and innovative mindset have contributed to the advancement of various pharmaceutical products, enhancing the company's research capabilities and therapeutic offerings.
Collaborations
In his endeavors, Joseph has collaborated with notable coworkers such as Scott Kevin Thompson and Lara Kallander. Their combined expertise and teamwork have allowed for the exploration of new domains in pharmaceutical innovation, leading to the successful development of several impactful inventions.
Conclusion
Joseph Marino's contributions to the field of pharmaceuticals through his inventive patents underscore his role as a notable inventor. His work not only enriches the scientific community but also holds promise for future advancements in medical treatments. With an ongoing focus on innovation and collaboration, Joseph continues to influence the pharmaceutical landscape positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile